NDC 16729-521

Vigabatrin

Vigabatrin

Vigabatrin is a Oral Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Accord Healthcare Inc.. The primary component is Vigabatrin.

Product ID16729-521_c129f384-a669-2281-e053-2a95a90af605
NDC16729-521
Product TypeHuman Prescription Drug
Proprietary NameVigabatrin
Generic NameVigabatrin
Dosage FormPowder, For Solution
Route of AdministrationORAL
Marketing Start Date2021-04-28
Marketing CategoryANDA /
Application NumberANDA214425
Labeler NameAccord Healthcare Inc.
Substance NameVIGABATRIN
Active Ingredient Strength500 mg/1
Pharm ClassesAnti-epileptic Agent [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 16729-521-11

50 POWDER, FOR SOLUTION in 1 CARTON (16729-521-11)
Marketing Start Date2021-04-28
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Vigabatrin" or generic name "Vigabatrin"

NDCBrand NameGeneric Name
0591-3851VigabatrinVigabatrin
0591-3955vigabatrinvigabatrin
16729-521VigabatrinVigabatrin
43598-651VigabatrinVigabatrin
43598-697VigabatrinVigabatrin
49884-358VIGABATRINvigabatrin
67877-674VIGABATRINVIGABATRIN
69097-964VIGABATRINvigabatrin
69238-1425VigabatrinVigabatrin
67386-111SABRILvigabatrin
67386-211SABRILvigabatrin
31722-009vigabatrin for oral solutionvigabatrin
0054-0702Vigabatrin for oral solution USP, 500 mgVigabatrin
0245-0556VIGADRONEvigabatrin

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.